Authors
Vincent Mangematin, Stéphane Lemarié, Jean-Pierre Boissin, David Catherine, Frédéric Corolleur, Roger Coronini, Michel Trommetter
Publication date
2003/4/1
Journal
Research Policy
Volume
32
Issue
4
Pages
621-638
Publisher
North-Holland
Description
Biotechnology is an emergent sector based on the creation of research-intensive Small and Medium Enterprises (SMEs). While some SMEs are growing, most of them remain small, even those set-up several years ago. What is the pattern of development of the biotech sector? What are the patterns of development of firms? Studies on the development of high-tech SMEs have focused on a business model, in which entrepreneurs rely on growth forecasts to persuade capital investors (business angels and venture capitalists) to invest in a radical innovation project. Firms aim for a world market to industrialise their innovation, and initial public offering (IPO) enables initial investors to make profits that offset risky initial investment. While this model is appealing, it is simply one of the possible models of biotechnology development. Some firms are not designed to experience exponential growth, and choose to target local …
Total citations
2002200320042005200620072008200920102011201220132014201520162017201820192020202120222023202417791317191120142823141619142081110894
Scholar articles